Casey Wang, MD
Dermatology · Houston, TXNPI 1295172823
Payments from drug & device makers
Across 468 payments — averaging $54.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$9K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$6K
- AbbVie$3K
- Sanofi$1K
- Johnson & Johnson$998
- Arcutis Biotherapeutics, Inc.$944
- plus $5K from 24 others
Across 8 payments — averaging $175.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
What the payments were for
- Consulting fees$9,88843%
- Travel & lodging$1,4987%
- Food & beverage$11,38750%
- Education$2041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 39 | $8,969 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $5,678 |
| AbbVie(2 entities) | 116 | $2,608 |
| Sanofi | 27 | $1,052 |
| Johnson & Johnson | 37 | $998 |
| Arcutis Biotherapeutics, Inc. | 37 | $944 |
| Sun Pharmaceutical Industries Inc. | 29 | $874 |
| Pfizer | 38 | $602 |
| Lilly USA, LLC | 24 | $597 |
| E.r. Squibb & Sons, L.L.C. | 6 | $561 |
| Regeneron Healthcare Solutions, Inc. | 14 | $442 |
| Dermavant Sciences, Inc. | 20 | $298 |
| VYNE Pharmaceuticals Inc. | 7 | $270 |
| UCB, Inc. | 5 | $252 |
| Novartis | 13 | $250 |
| Boehringer Ingelheim | 7 | $195 |
| Dermira, Inc. | 1 | $125 |
| Journey Medical Corporation | 1 | $124 |
| Organon | 9 | $112 |
| Galderma Laboratories, L.p. | 7 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Amgen | 3 | $58 |
| Mayne Pharma Commercial LLC | 3 | $55 |
| Fresenius Kabi USA, LLC | 2 | $50 |
| Verrica Pharmaceuticals Inc. | 2 | $44 |
| Biofrontera Inc. | 2 | $32 |
| Almirall LLC | 1 | $21 |
| LEO Pharma Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| EPI Health, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,428 in reported general payments places this provider in the 85th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 32 | $1,420 |
| Fluorouracil | 22 | $1,414 |
| Desonide | 23 | $970 |
| Triamcinolone Acetonide | 75 | $812 |
| Ketoconazole | 47 | $659 |
| Fluocinonide | 19 | $622 |
| Clobetasol Propionate | 16 | $468 |
| Hydroxychloroquine Sulfate | 11 | $233 |
| Hydrocortisone | 17 | $115 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Houston
- Michael MigdenHouston$3.7M
- Megan CouvillionHouston$3M
- Alpesh DesaiHouston$2.7M
- Suzanne BruceHouston$2.2M
- Geeta PatelHouston$626K
- Madeleine DuvicHouston$597K
- Auris HuenHouston$323K
- Catherine PapasakelariouHouston$289K
- Anisha PatelHouston$268K
- Stephen TyringWebster$14.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.